{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:30:56Z","timestamp":1792722656973,"version":"4.5.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS100608"],"award-info":[{"award-number":["NS100608"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS115388"],"award-info":[{"award-number":["NS115388"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS120384"],"award-info":[{"award-number":["NS120384"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T35AG026736"],"award-info":[{"award-number":["T35AG026736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005224","name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Damage to axons is a core feature of ischemic stroke and cerebrovascular disease. The burden of axonal injury is correlated with the acute clinical deficits, the underlying burden of ischemic brain injury, the prognosis of recovery, and may be a meaningful therapeutic target for brain repair. Neurofilament light chain (NfL) has been identified as a blood-based biomarker that reflects neuroaxonal damage resulting from stroke. However, the utility of NfL as a blood-based biomarker in stroke is confounded by studies examining different temporal windows and patient populations. We conducted a systematic review and meta-analysis to verify the utility of blood NfL as a diagnostic, prognostic, and monitoring stroke biomarker. Nineteen studies reporting serum\/plasma NfL values for a total of 4,237 distinct patients with stroke were identified. Using available summary data from the 10 studies that employed a common immunoassay platform, we utilized random effects linear mixed modeling and weighted averages to create a phasic model of serum\/plasma NfL values in distinct time periods of acute stroke. Weighted averages show that blood NfL levels vary significantly across three distinct temporal epochs of acute (0\u20137 days), subacute (9\u201390 days), and chronic (&amp;gt;90 days) stroke with a steep peak in the early subacute period between 14 and 21 days after stroke. Blood NfL values can function as a diagnostic biomarker in distinguishing acute ischemic stroke from transient ischemic attack as well as amongst other cerebrovascular subtypes. Release of NfL into the bloodstream after stroke follows a distinct temporal dynamic that lags several weeks behind stroke onset and reliably associates with a stroke diagnosis despite some variability based on stroke subtype and severity. Identification of these temporal dynamics and the contribution of co- existent cerebrovascular disease states can improve the value of NfL as a stroke biomarker.<\/jats:p>","DOI":"10.3389\/fneur.2022.841898","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T09:18:17Z","timestamp":1652692697000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Temporal Patterning of Neurofilament Light as a Blood-Based Biomarker for Stroke: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Jasmin D.","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Martirosian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis S.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Lorenzo","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Uphaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"W\u00f6lfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Tiedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Hinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the DEMDAS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1111\/ejn.14678","article-title":"Rapid degeneration of neurons in the penumbra region following a small, focal ischemic stroke","volume":"52","author":"Fifield","year":"2020","journal-title":"Eur J Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1161\/STROKEAHA.119.025898","article-title":"Corticospinal Tract Injury Estimated From Acute Stroke Imaging Predicts Upper Extremity Motor Recovery After Stroke","volume":"50","author":"Lin","year":"2019","journal-title":"Stroke."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/STROKEAHA.118.023361","article-title":"Response to late-window endovascular revascularization is associated with collateral status in basilar artery occlusion","volume":"50","author":"Alemseged","year":"2019","journal-title":"Stroke"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/1747493017711816","article-title":"Agreed definitions and a shared vision for new standards in stroke recovery research: the stroke recovery and rehabilitation roundtable taskforce","volume":"12","author":"Bernhardt","year":"2017","journal-title":"Int J Stroke."},{"key":"B9","volume-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","year":"2016"},{"key":"B10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3758\/s13428-016-0809-y","article-title":"Evaluating significance in linear mixed-effects models in R","volume":"49","author":"Luke","year":"2017","journal-title":"Behav Res Methods."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1212\/WNL.0000000000004645","article-title":"Serum neurofilament light is sensitive to active cerebral small vessel disease","volume":"89","author":"Gattringer","year":"2017","journal-title":"Neurology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1177\/0271678X18775215","article-title":"Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors","volume":"39","author":"Pinter","year":"2019","journal-title":"J Cereb Blood Flow Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5853\/jos.2017.02565","article-title":"Serum neurofilament light chain levels are related to small vessel disease burden","volume":"20","author":"Duering","year":"2018","journal-title":"J Stroke."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1338","DOI":"10.1212\/WNL.0000000000006282","article-title":"Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke","volume":"91","author":"Tiedt","year":"2018","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/acn3.678","article-title":"Serum neurofilament light correlates with CADASIL disease severity and survival","volume":"6","author":"Gravesteijn","year":"2019","journal-title":"Ann Clin Transl Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2018.12.042","article-title":"Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke","volume":"698","author":"Pujol-Calderon","year":"2019","journal-title":"Neurosci Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1161\/STROKEAHA.119.024941","article-title":"Serum NfL (neurofilament light chain) levels and incident stroke in adults with diabetes mellitus","volume":"50","author":"Korley","year":"2019","journal-title":"Stroke."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.008","article-title":"Serum neurofilament light chain concentration correlates with infarct volume but not prognosis in acute ischemic stroke","volume":"28","author":"Onatsu","year":"2019","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s00415-019-09477-9","article-title":"Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction","volume":"266","author":"Pedersen","year":"2019","journal-title":"J Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1161\/STROKEAHA.119.026410","article-title":"NfL (neurofilament light chain) levels as a predictive marker for long-term outcome after ischemic stroke","volume":"50","author":"Uphaus","year":"2019","journal-title":"Stroke."},{"key":"B22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s12640-019-00159-y","article-title":"Serum neurofilament light predicts severity and prognosis in patients with ischemic stroke","volume":"37","author":"Wang","year":"2020","journal-title":"Neurotox Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.genhosppsych.2020.01.006","article-title":"Association of serum biomarker neurofilament light concentration with post-stroke depression: a preliminary study","volume":"64","author":"Zhao","year":"2020","journal-title":"Gen Hosp Psychiatry."},{"key":"B24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-020-01813-5","article-title":"Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL","volume":"17","author":"Chen","year":"2020","journal-title":"J Neuroinflammation."},{"key":"B25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fneur.2020.00448","article-title":"Acute neurofilament light chain plasma levels correlate with stroke severity and clinical outcome in ischemic stroke patients","volume":"11","author":"Nielsen","year":"2020","journal-title":"Front Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5853\/jos.2019.02845","article-title":"Serum neurofilament light chain is associated with incident lacunes in progressive cerebral small vessel disease","volume":"22","author":"Peters","year":"2020","journal-title":"J Stroke"},{"key":"B27","doi-asserted-by":"publisher","first-page":"eaay1913","DOI":"10.1126\/scitranslmed.aay1913","article-title":"Plasma neurofilament light predicts mortality in patients with stroke","volume":"12","author":"Gendron","year":"2020","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000440774","article-title":"Serum neurofilament light chain levels are associated with clinical characteristics and outcome in patients with cervical artery dissection","volume":"40","author":"Traenka","year":"2015","journal-title":"Cerebrovasc Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/ene.13554","article-title":"Serum neurofilament light chain in patients with acute cerebrovascular events","volume":"25","author":"De Marchis","year":"2018","journal-title":"Eur J Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"146861","DOI":"10.1016\/j.brainres.2020.146861","article-title":"Diagnosis of ischemic stroke using circulating levels of brain-specific proteins measured via high-sensitivity digital ELISA","volume":"1739","author":"O'Connell","year":"2020","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin Chem Lab Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/WCO.0000000000000149","article-title":"The back and forth of axonal injury and repair after stroke","volume":"27","author":"Hinman","year":"2014","journal-title":"Curr Opin Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/01.STR.0000196957.55928.ab","article-title":"Time is brain\u2013quantified","volume":"37","author":"Saver","year":"2006","journal-title":"Stroke."},{"key":"B35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiol Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000499666","article-title":"Post-stroke blood-brain barrier disruption and poor functional outcome in patients receiving thrombolytic therapy","volume":"47","author":"Nadareishvili","year":"2019","journal-title":"Cerebrovasc Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1161\/STROKEAHA.116.013805","article-title":"Identification of reversible disruption of the human blood-brain barrier following acute ischemia","volume":"47","year":"2016","journal-title":"Stroke."},{"key":"B38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3233\/NRE-2009-0480","article-title":"The role of the corticospinal tract in motor recovery in patients with a stroke: a review","volume":"24","author":"Jang","year":"2009","journal-title":"NeuroRehabilitation."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1212\/WNL.0000000000008755","article-title":"Motor tract integrity predicts walking recovery: a diffusion MRI study in subacute stroke","volume":"94","author":"Soulard","year":"2020","journal-title":"Neurology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/STROKEAHA.120.031490","article-title":"Quality of life in physical, social, and cognitive domains improves with endovascular therapy in the DEFUSE 3 Trial","volume":"52","author":"Polding","year":"2021","journal-title":"Stroke."},{"key":"B41","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/alz.12215","article-title":"MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols","volume":"17","author":"Wilcock","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e499","DOI":"10.1161\/STROKEAHA.120.031611","article-title":"Cognitive impairment and dementia after stroke: design and rationale for the discovery study","volume":"52","author":"Rost","year":"2021","journal-title":"Stroke"},{"key":"B43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/jnnp-2016-314587","article-title":"Principles of precision medicine in stroke","volume":"88","author":"Hinman","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/brain\/awaa342","article-title":"Blennow, and I. Alzheimer's Disease Neuroimaging, Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease","volume":"143","author":"Benedet","year":"2020","journal-title":"Brain."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1212\/WNL.0000000000003912","article-title":"Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports","volume":"88","author":"Shahim","year":"2017","journal-title":"Neurology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/alz.12496","article-title":"Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT).S Alzheimers Dement","author":"Pajewski","year":"2021"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.841898\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T09:18:22Z","timestamp":1652692702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.841898\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":47,"alternative-id":["10.3389\/fneur.2022.841898"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.841898","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"article-number":"841898"}}